DD151445A5 - Verfahren zur herstellung von alpha,alpha,alpha-trifluor(aminoaryl)-aethanolen,estern und aethern - Google Patents

Verfahren zur herstellung von alpha,alpha,alpha-trifluor(aminoaryl)-aethanolen,estern und aethern Download PDF

Info

Publication number
DD151445A5
DD151445A5 DD79216684A DD21668479A DD151445A5 DD 151445 A5 DD151445 A5 DD 151445A5 DD 79216684 A DD79216684 A DD 79216684A DD 21668479 A DD21668479 A DD 21668479A DD 151445 A5 DD151445 A5 DD 151445A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
radical
acid
hydrogen
formula
Prior art date
Application number
DD79216684A
Other languages
German (de)
English (en)
Inventor
Michel Vincent
Georges Remond
Jacques Bure
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of DD151445A5 publication Critical patent/DD151445A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
DD79216684A 1978-11-03 1979-11-05 Verfahren zur herstellung von alpha,alpha,alpha-trifluor(aminoaryl)-aethanolen,estern und aethern DD151445A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7831096A FR2440353A1 (fr) 1978-11-03 1978-11-03 Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament

Publications (1)

Publication Number Publication Date
DD151445A5 true DD151445A5 (de) 1981-10-21

Family

ID=9214422

Family Applications (2)

Application Number Title Priority Date Filing Date
DD79216691A DD147048A5 (de) 1978-11-03 1979-11-05 Verfahren zur herstellung pharmazeutischer zusammensetzungen
DD79216684A DD151445A5 (de) 1978-11-03 1979-11-05 Verfahren zur herstellung von alpha,alpha,alpha-trifluor(aminoaryl)-aethanolen,estern und aethern

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DD79216691A DD147048A5 (de) 1978-11-03 1979-11-05 Verfahren zur herstellung pharmazeutischer zusammensetzungen

Country Status (27)

Country Link
US (2) US4285943A (xx)
JP (2) JPS5566510A (xx)
AR (2) AR223989A1 (xx)
AT (1) AT368483B (xx)
AU (1) AU527630B2 (xx)
BE (2) BE879787A (xx)
CA (2) CA1142087A (xx)
CH (2) CH647225A5 (xx)
DD (2) DD147048A5 (xx)
DE (2) DE2944293A1 (xx)
DK (2) DK461679A (xx)
EG (1) EG14114A (xx)
ES (1) ES485656A0 (xx)
FI (2) FI793445A (xx)
FR (1) FR2440353A1 (xx)
GB (2) GB2038802B (xx)
GR (2) GR68015B (xx)
IL (2) IL58620A (xx)
IT (2) IT7950715A0 (xx)
MA (2) MA18628A1 (xx)
NL (2) NL7908101A (xx)
NZ (2) NZ192021A (xx)
OA (2) OA06372A (xx)
PT (2) PT70407A (xx)
SE (2) SE7909105L (xx)
SU (1) SU925247A3 (xx)
ZA (2) ZA795871B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US6673784B1 (en) * 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
DK2805746T3 (da) 2009-02-16 2020-08-10 Nogra Pharma Ltd Alkylamido-forbindelser og anvendelser deraf
WO2013117744A2 (en) 2012-02-09 2013-08-15 Nogra Pharma Limited Methods of treating fibrosis
MX2014012652A (es) 2012-04-18 2014-11-25 Nogra Pharma Ltd Metodo de tratamiento de la intolerancia a la lactosa.
US11905232B2 (en) 2019-02-08 2024-02-20 Nogra Pharma Limited Process of making 3-(4′-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3142683A (en) * 1961-08-14 1964-07-28 Parke Davis & Co 1-pyridyl-1, 2-diaryl-3-trifluoro-propan-2-ols and a process for their preparation
US3531487A (en) * 1966-10-25 1970-09-29 Hoffmann La Roche 4-(n,n-disubstituted-amino)-piperidines
DE1618007A1 (de) * 1967-05-09 1970-10-29 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-monohalogenphenylaethanolaminen
US3821231A (en) * 1971-10-15 1974-06-28 E Lavrinovich Method for preparation of n-substituted 4-aniline piperidines
GB1411783A (en) * 1972-02-24 1975-10-29 Wyeth John & Brother Ltd Piperidine derivatives
FR2340734A1 (fr) * 1976-02-13 1977-09-09 Roussel Uclaf Nouveaux derives de la m-trifluoromethylphenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
DE2659117A1 (de) * 1976-12-28 1978-07-06 Consortium Elektrochem Ind Trichlormethyl-(3-pyridyl)-carbinol
GR66480B (xx) * 1977-10-07 1981-03-24 Science Union & Cie

Also Published As

Publication number Publication date
AT368483B (de) 1982-10-11
BE879786A (fr) 1980-04-30
IL58620A0 (en) 1980-02-29
ZA795870B (en) 1980-10-29
BE879787A (fr) 1980-04-30
MA18628A1 (fr) 1980-07-01
CA1142087A (fr) 1983-03-01
ZA795871B (en) 1980-10-29
NZ192021A (en) 1982-09-07
JPS5566510A (en) 1980-05-20
FR2440353A1 (fr) 1980-05-30
GR69726B (xx) 1982-07-09
OA06372A (fr) 1981-08-31
DE2944293A1 (de) 1980-05-08
CA1139763A (fr) 1983-01-18
IL58620A (en) 1982-12-31
IT7950715A0 (it) 1979-10-31
US4404215A (en) 1983-09-13
CH647225A5 (fr) 1985-01-15
SE7909105L (sv) 1980-05-04
NL7908101A (nl) 1980-05-07
ATA701679A (de) 1982-02-15
DK461679A (da) 1980-05-04
GR68015B (xx) 1981-10-27
AR223990A1 (es) 1981-10-15
ES8101538A1 (es) 1980-12-16
SE7909106L (sv) 1980-05-04
GB2034587B (en) 1983-02-09
GB2038802A (en) 1980-07-30
AR223989A1 (es) 1981-10-15
PT70408A (fr) 1979-12-01
EG14114A (en) 1983-03-31
FI793445A (fi) 1980-05-04
FI793444A (fi) 1980-05-04
IL58621A0 (en) 1980-02-29
ES485656A0 (es) 1980-12-16
DE2944294A1 (de) 1980-05-08
CH641043A5 (fr) 1984-02-15
DD147048A5 (de) 1981-03-18
IT7950714A0 (it) 1979-10-31
SU925247A3 (ru) 1982-04-30
GB2034587A (en) 1980-06-11
GB2038802B (en) 1982-12-08
JPS5566548A (en) 1980-05-20
AU5241679A (en) 1980-05-08
US4285943A (en) 1981-08-25
PT70407A (en) 1979-12-01
MA18629A1 (fr) 1980-07-01
OA06373A (fr) 1981-08-31
AU527630B2 (en) 1983-03-17
NL7908099A (nl) 1980-05-07
DK461579A (da) 1980-05-04
NZ192020A (en) 1982-12-21

Similar Documents

Publication Publication Date Title
DE2705446C2 (xx)
DE2636582C2 (de) 2-Amino-3-(5- und 6-)benzoylphenylessigsäuren, deren Ester und Metallsalze, Verfahren zur Herstellung dieser Verbindungen und Arzneimittel diese enthaltend
DE3026201A1 (de) Aminoaetheroxide, verfahren zu ihrer herstellung sowie ihre therapeutische verwendung
DE2537070C2 (xx)
DE2923368A1 (de) Neue 5-fluor-( beta -uridin oder 2'-desoxy- beta -uridin)-derivate, verfahren zur herstellung derselben und carcinostatische mittel mit einem gehalt derselben
DE2234651C3 (de) Eckige Klammer auf l-(p-Chlorbenzoyl)-5-methoxy-2-methyl-3-indol] -acetoxj essigsaure, ihre Salze mit Basen, Verfahren zu ihrer Herstellung sowie pharmakologische Zubereitungen
DD209446A5 (de) Verfahren zur herstellung von neuen aromatischen verbindungen
DE2634903A1 (de) Neue thienopyridinderivate und sie enthaltende arzneimittel
DD151445A5 (de) Verfahren zur herstellung von alpha,alpha,alpha-trifluor(aminoaryl)-aethanolen,estern und aethern
DE3035086A1 (de) Cyclohexancarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende mittel
DD251126A1 (de) Verfahren zur herstellung neuer 2-arylsulfonamido-benzo- und -acetophenone und deren oxime, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE1618465C3 (de) Phenylessigsäureester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0072960B1 (de) 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1932389B2 (de) Neue 2-Naphthyl-2-methyläthanole und deren Acetate, sie enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE2427272C3 (de) 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum
DE2502504C3 (de) Phenothiazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2802306A1 (de) Azacycloalkane, azacycloalkene und ihre derivate
DE2253914A1 (de) Neue chromonderivate und verfahren zu ihrer herstellung
DE2351292C3 (de) 2,10-Dichlor-6-äthoxycarbonyl-12-methyl-12H-dibenzo[d,g][1,3]dioxocin und Verfahren zu dessen Herstellung sowie diese Verbindung enthaltende Arzneimittel
DE2412388A1 (de) Dibenzothiophenderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE2341507A1 (de) Neue biphenylderivate und verfahren zur herstellung
DE3034005C2 (de) Indolessigsäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE2722773A1 (de) Neue derivate des dibenzo eckige klammer auf de,h eckige klammer zu chinolins, ihre herstellung und die sie enthaltenden zusammensetzungen
DE2346057A1 (de) Lipidsenkende pharmazeutische zubereitungen
DE1668968A1 (de) Neue organische Verbindungen